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Introduction:  Widespread use of conventional antibiotics accompanied by natural selection of 
the infectious bacteria has led to the emergence of drug resistance among the bacterial 
population.  Thus, there is an increasing need for novel, more effective antibiotic compounds 
successful in treating bacterial infections resistant to available therapies.  SecA, an indispensable 
ATPase of the protein translocation machinery, acts as a motor present in all bacteria; it couples 
ATP hydrolysis with pre-protein translocation through SecYEG channels1 across the bacterial 
cytoplasmic membrane2.  While bacterial SecYEG channels enhance the effectiveness as well as 
specificity of protein translocation within the bacteria, SecA is necessary for promoting both 
protein translocation as well as ion channel activity1. 
 
Methods:  SecA inhibitor, SCA-107 was used to perform EMS (0.5%) mutagenesis on E. coli 
NR698.  Mutagenesis increased the frequency of mutations without unnecessary killing of cells.  
Along with isolating the mutant, DNA sequencing was completed.   
Results:  After EMS treatment and treatment with both 10 and 20 µM SCA- 107, it appears that 
the EMS treated NR698 could have produced mutants resistant against 10 and 20 µM SCA-107.  
Continued resistance appeared after the mutants were screened again on LB only agar plates 
treated with 20 µM SCA-107.   
 
Conclusion:  It appears that the particular strain of E. coli NR698 used successfully developed 
mutants capable of withstanding treatment using 20 µM SCA-107.  The findings from the EMS 
(0.5%) mutagenesis treatment appear promising and further research is needed to confirm results 
obtained.  Following additional testing with higher concentrations of SCA- 107, DNA extraction 
and PCR will be performed on the mutants.  Verification is needed to confirm that the mutations 
are SecA mutations.  
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